Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Methotrexate oral solution - Azurity Pharmaceuticals

Next Previous
Drug Profile

Methotrexate oral solution - Azurity Pharmaceuticals

Alternative Names: Methotrexate oral liquid - Azurity Pharmaceuticals; Methotrexate sodium - Azurity Pharmaceuticals; XATMEP

Latest Information Update: 21 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Silvergate Pharmaceuticals
  • Developer Azurity Pharmaceuticals
  • Class Abortifacients; Anti-inflammatories; Antiasthmatics; Antifibrotics; Antineoplastics; Antipsoriatics; Antirheumatics; Benzamides; Disease-modifying antirheumatics; Eye disorder therapies; Glutamates; Heart failure therapies; Pterins; Small molecules
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Juvenile rheumatoid arthritis; Precursor cell lymphoblastic leukaemia-lymphoma
  • New Molecular Entity No

Highest Development Phases

  • Marketed Juvenile rheumatoid arthritis; Precursor cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 12 Jun 2019 CutisPharma is now called Azurity Pharmaceuticals
  • 12 Jun 2019 Silvergate Pharmaceuticals has been acquired and merged into CutisPharma
  • 25 May 2017 Chemical structure information added

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top